Hält derzeit Positionen bei DexCom Inc, AxoGen Inc and Alphatec Holdings Inc
Position | Company | Period |
---|---|---|
Chief Financial Officer, Chief Operating Officer | DexCom Inc | 1. Oktober 2019 - |
Director | AxoGen Inc | 15. Mai 2019 - |
Independent Director | Alphatec Holdings Inc | 1. Oktober 2017 - |
Chief Financial Officer, Executive Vice President | DexCom Inc | 1. September 2017 - 1. Oktober 2019 |
Chief Financial Officer, Executive Vice President Head of Strategy and Corporate Integrity | NuVasive Inc | 1. August 2014 - 25. August 2017 |
Executive Vice President - Finance and Investor Relations | NuVasive Inc | 1. Februar 2014 - 1. August 2014 |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2024-03-08 | 2024-03-07 |
Alphatec Holdings Inc
(ATEC)
|
K Kauf |
20.000
+3.6%
12,83256.600 USD |
20.000 +3.6% | 12,83 | 256.600 USD | |
2024-03-01 | 2024-02-29 |
iRhythm Technologies Inc
(IRTC)
|
V Verkauf |
24.701
-12.1%
121,963.012.534 USD |
24.701 -12.1% | 121,96 | 3.012.534 USD | |
2022-11-04 | 2022-11-02 |
iRhythm Technologies Inc
(IRTC)
|
V Verkauf |
12.415
-12.2%
122,501.520.838 USD |
12.415 -12.2% | 122,50 | 1.520.838 USD | |
2022-11-04 | 2022-11-02 |
iRhythm Technologies Inc
(IRTC)
|
V Verkauf |
284
-0.3%
118,1733.560 USD |
284 -0.3% | 118,17 | 33.560 USD | |
2021-03-12 | 2021-03-10 |
DexCom Inc
(DXCM)
|
V Verkauf |
6.509
-12.6%
362,222.357.688 USD |
6.509 -12.6% | 362,22 | 2.357.688 USD | |
2020-09-11 | 2020-09-10 |
DexCom Inc
(DXCM)
|
GV Geplanter Verkauf |
171
-0.4%
405,3369.311 USD |
171 -0.4% | 405,33 | 69.311 USD | |
2020-09-11 | 2020-09-10 |
DexCom Inc
(DXCM)
|
GV Geplanter Verkauf |
272
-0.6%
403,87109.854 USD |
272 -0.6% | 403,87 | 109.854 USD | |
2020-09-11 | 2020-09-10 |
DexCom Inc
(DXCM)
|
GV Geplanter Verkauf |
2.159
-4.6%
402,72869.471 USD |
2.159 -4.6% | 402,72 | 869.471 USD | |
2020-09-11 | 2020-09-10 |
DexCom Inc
(DXCM)
|
GV Geplanter Verkauf |
3.157
-6.3%
401,791.268.455 USD |
3.157 -6.3% | 401,79 | 1.268.455 USD | |
2020-09-11 | 2020-09-10 |
DexCom Inc
(DXCM)
|
GV Geplanter Verkauf |
3.017
-5.7%
399,911.206.536 USD |
3.017 -5.7% | 399,91 | 1.206.536 USD | |
2020-09-11 | 2020-09-10 |
DexCom Inc
(DXCM)
|
GV Geplanter Verkauf |
1.594
-2.9%
398,98635.978 USD |
1.594 -2.9% | 398,98 | 635.978 USD | |
2020-09-11 | 2020-09-10 |
DexCom Inc
(DXCM)
|
GV Geplanter Verkauf |
1.300
-2.3%
397,76517.090 USD |
1.300 -2.3% | 397,76 | 517.090 USD | |
2020-09-11 | 2020-09-10 |
DexCom Inc
(DXCM)
|
GV Geplanter Verkauf |
523
-0.9%
397,03207.647 USD |
523 -0.9% | 397,03 | 207.647 USD | |
2020-09-11 | 2020-09-09 |
DexCom Inc
(DXCM)
|
V Verkauf |
1.579
-2.7%
398,30628.919 USD |
1.579 -2.7% | 398,30 | 628.919 USD | |
2020-09-11 | 2020-09-09 |
DexCom Inc
(DXCM)
|
V Verkauf |
3.297
-5.4%
398,301.313.202 USD |
3.297 -5.4% | 398,30 | 1.313.202 USD | |
2020-09-11 | 2020-09-09 |
DexCom Inc
(DXCM)
|
V Verkauf |
8.010
-11.6%
398,303.190.399 USD |
8.010 -11.6% | 398,30 | 3.190.399 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
GV Geplanter Verkauf |
100
-0.1%
244,7824.478 USD |
100 -0.1% | 244,78 | 24.478 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
GV Geplanter Verkauf |
400
-0.6%
244,0197.604 USD |
400 -0.6% | 244,01 | 97.604 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
GV Geplanter Verkauf |
500
-0.7%
241,06120.532 USD |
500 -0.7% | 241,06 | 120.532 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
GV Geplanter Verkauf |
1.100
-1.5%
239,63263.596 USD |
1.100 -1.5% | 239,63 | 263.596 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
GV Geplanter Verkauf |
600
-0.8%
238,29142.972 USD |
600 -0.8% | 238,29 | 142.972 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
GV Geplanter Verkauf |
641
-0.9%
237,10151.980 USD |
641 -0.9% | 237,10 | 151.980 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
GV Geplanter Verkauf |
472
-0.6%
235,90111.344 USD |
472 -0.6% | 235,90 | 111.344 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
GV Geplanter Verkauf |
300
-0.4%
234,2370.270 USD |
300 -0.4% | 234,23 | 70.270 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
GV Geplanter Verkauf |
200
-0.3%
232,0046.400 USD |
200 -0.3% | 232,00 | 46.400 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
GV Geplanter Verkauf |
200
-0.3%
228,8645.772 USD |
200 -0.3% | 228,86 | 45.772 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
GV Geplanter Verkauf |
400
-0.5%
227,5691.025 USD |
400 -0.5% | 227,56 | 91.025 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
GV Geplanter Verkauf |
457
-0.6%
223,62102.196 USD |
457 -0.6% | 223,62 | 102.196 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
V Verkauf |
200
-0.3%
220,5044.100 USD |
200 -0.3% | 220,50 | 44.100 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
GV Geplanter Verkauf |
200
-0.3%
219,3743.873 USD |
200 -0.3% | 219,37 | 43.873 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
GV Geplanter Verkauf |
583
-0.8%
218,84127.582 USD |
583 -0.8% | 218,84 | 127.582 USD | |
2020-03-13 | 2020-03-11 |
DexCom Inc
(DXCM)
|
V Verkauf |
5.963
-7.3%
265,431.582.735 USD |
5.963 -7.3% | 265,43 | 1.582.735 USD | |
2020-03-13 | 2020-03-11 |
DexCom Inc
(DXCM)
|
V Verkauf |
129
-0.2%
251,0332.383 USD |
129 -0.2% | 251,03 | 32.383 USD | |
2020-03-13 | 2020-03-11 |
DexCom Inc
(DXCM)
|
V Verkauf |
116
-0.1%
246,6128.607 USD |
116 -0.1% | 246,61 | 28.607 USD | |
2020-03-10 | 2020-03-09 |
DexCom Inc
(DXCM)
|
GV Geplanter Verkauf |
891
-1.1%
261,00232.551 USD |
891 -1.1% | 261,00 | 232.551 USD | |
2019-09-12 | 2019-09-10 |
DexCom Inc
(DXCM)
|
GV Geplanter Verkauf |
600
-0.9%
144,5786.742 USD |
600 -0.9% | 144,57 | 86.742 USD | |
2019-09-12 | 2019-09-10 |
DexCom Inc
(DXCM)
|
GV Geplanter Verkauf |
406
-0.6%
143,5758.288 USD |
406 -0.6% | 143,57 | 58.288 USD | |
2019-09-12 | 2019-09-10 |
DexCom Inc
(DXCM)
|
GV Geplanter Verkauf |
1.289
-1.8%
142,16183.247 USD |
1.289 -1.8% | 142,16 | 183.247 USD | |
2019-09-12 | 2019-09-10 |
DexCom Inc
(DXCM)
|
GV Geplanter Verkauf |
3.725
-4.9%
141,62527.517 USD |
3.725 -4.9% | 141,62 | 527.517 USD | |
2019-09-12 | 2019-09-10 |
DexCom Inc
(DXCM)
|
GV Geplanter Verkauf |
2.500
-3.2%
140,47351.181 USD |
2.500 -3.2% | 140,47 | 351.181 USD | |
2019-09-12 | 2019-09-10 |
DexCom Inc
(DXCM)
|
GV Geplanter Verkauf |
1.800
-2.2%
139,29250.716 USD |
1.800 -2.2% | 139,29 | 250.716 USD | |
2019-09-11 | 2019-09-09 |
DexCom Inc
(DXCM)
|
V Verkauf |
11.049
-12.1%
150,111.658.578 USD |
11.049 -12.1% | 150,11 | 1.658.578 USD | |
2019-09-11 | 2019-09-09 |
DexCom Inc
(DXCM)
|
V Verkauf |
637
-0.7%
145,4592.654 USD |
637 -0.7% | 145,45 | 92.654 USD | |
2019-05-30 | 2019-05-29 |
DexCom Inc
(DXCM)
|
GV Geplanter Verkauf |
3.376
-3.5%
119,30402.762 USD |
3.376 -3.5% | 119,30 | 402.762 USD | |
2019-05-30 | 2019-05-29 |
DexCom Inc
(DXCM)
|
GV Geplanter Verkauf |
5.498
-5.5%
118,73652.765 USD |
5.498 -5.5% | 118,73 | 652.765 USD | |
2019-03-13 | 2019-03-12 |
DexCom Inc
(DXCM)
|
V Verkauf |
5.358
-5.1%
142,79765.081 USD |
5.358 -5.1% | 142,79 | 765.081 USD | |
2018-09-12 | 2018-09-10 |
DexCom Inc
(DXCM)
|
V Verkauf |
7.149
-7.0%
143,761.027.706 USD |
7.149 -7.0% | 143,76 | 1.027.706 USD |